News

Kia ora.   We are writing to update you on the constrained supply of oxytocin injection 10 IU per mL, 1 mL ampoule (Pharmacode: 2577046) from mid to late November 2025.   Medsafe has approved a labelling exemption for an alternative German product. The product should be available to order by the end of October 2025. The product is identical except the label on the ampoule is in German (as shown below). It will come in the standard New Zealand-labelled carton, and it will have the same...

Pharmac has confirmed it will fund an additional extended-release brand of methylphenidate - Methylphenidate Sandoz XR - from 1 December 2025.  This decision follows recent consultation and will help increase supply and provide more options for people who need ADHD treatments. Methylphenidate Sandoz XR will be available in the same strengths as Concerta – 18 mg, 27 mg, 36 mg, and 54 mg. It will be funded alongside currently available brands, under existing eligibility criteria.You can read...

Coming up in CPD: Goodfellow Symposium 2026 21/22 March 2026: Practical, evidence-based clinical skills you can use next week:  Check it out here . Herpes zoster and cardiovascular disease WEBINAR 4 November: Hasan Bhally and Rachael Niederer on understanding the burden and prevention of herpes zoster in patients with cardiovascular risk. Register here Beyond borders: Challenges in bariatric surgical tourism WEBINAR 11 November: Equipping clinicians to provide safe, non-judgemental,...

Heparin sodium inj 5,000 iu per ml, 5 ml ampoule (Brand change)  (Pharmacode: 2651815) The funded brand of heparin sodium injections (5,000 iu/ml 5 ml ampoules) is changing from Panpharma to Pfizer. Pfizer will be listed from 1 November 2025. A flyer for patients is available. Nonacog gamma [Recombinant Factor IX] (Rixubis) Inj 2,000 iu vial  (Pharmacode: 2487950) Due to recent high demand, Takeda, the supplier has low stock of the inj 2,000 iu vial of Rixubis. Takeda is working directly...

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 24 October 2025. It includes information on:  New updates R esolved Supply Issues 24-10-2025 Pharmac Weekly Update to Prescribers  in Primary Care Consultation now open - proposed changes to the Options for Investment list Pharmac is now consulting publicly on a proposal to bring greater clarity and transparency to how we manage medicine funding applications on the...

DBT Psychologist / Therapist / Mental Health Professional Permanent, part-time — 3 days per week Golden Bay, Tasman Kia ora — we’re recruiting. Te Whare Mahana Trust (TWM) is a warm mental health NGO seeking a skilled and compassionate DBT Psychologist, Therapist or Mental Health Professional with experience in DBT-PTSD or CBT and   EMDR - prolonged exposure . Join a committed   team delivering high-quality, evidence-based care in a supportive, person-centred environment where clinical...